Prevalence and Associated Factors of Sarcopenia Among Elderly Patients in Osteoporosis Clinic
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sarcopenia
- Sponsor
- Kowloon Hospital, Hong Kong
- Enrollment
- 94
- Locations
- 1
- Primary Endpoint
- Prevalence of Sarcopenia
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This was a cross-sectional study. Patients who attended the osteoporosis clinic of Kowloon Hospital from June to December 2022 were recruited.
Grip strength and appendicular skeletal muscle mass index were measured with a Jamar dynamometer and a bioimpedance analyser. Since most patients in our clinic are of Chinese ethnicity, the diagnostic criteria in the Consensus Update on Sarcopenia Diagnosis and Treatment by the Asian Working Group for Sarcopenia in 2019 was utilised. The diagnosis of sarcopenia was established by the presence of both low grip strength (Male: < 28 kg, Female < 18 kg) and low appendicular skeletal mass (Male: < 7.0 kg/m2, Female: < 5.7 kg/m2)
Investigators
Leung Hin Cheung
Principal Investigator
Kowloon Hospital, Hong Kong
Eligibility Criteria
Inclusion Criteria
- •Patients aged 60 years old or above
- •Diagnosed with osteoporosis by: Fragility fracture or T-score ≤-2.5 SDs at any site on DXA scan and;
- •Able to read and write Chinese
Exclusion Criteria
- •Unable to maintain standing posture for bioimpedance analysis
- •Modified Functional Ambulation Classification (MFAC) ≤ IV
- •Incompetent in giving consent
- •Unable to follow instructions
- •Implanted with metal in any of four limbs
- •Implanted with pacemaker, implantable cardioverter defibrillator or any other types of electrical device
Outcomes
Primary Outcomes
Prevalence of Sarcopenia
Time Frame: June - December 2022
The diagnosis of sarcopenia would be established by the co-existence of low grip strength and low appendicular skeletal muscle mass.
Grip strength
Time Frame: June - December 2022
Grip strength would be measured with Jamar digital dynamometer.
Appendicular Skeletal Muscle Mass Index
Time Frame: June - December 2022
Appendicular Skeletal Muscle Mass Index would be measured with bioimpedance analyzer.
Secondary Outcomes
- Association between BMI and Sarcopenia.(June - December 2022)
- Association between Frailty and Sarcopenia.(June - December 2022)
- Association between Bone Mineral Densities and Sarcopenia(June - December 2022)
- Association between Charlson Comorbidities Index and Sarcopenia(June - December 2022)